IMPORTANT SAFETY INFORMATION
DIASTAT
® AcuDial™ (diazepam rectal gel) is a gel formulation of
diazepam intended for rectal administration in the management of selected,
refractory patients with epilepsy, on stable regimens of AEDs, who require
intermittent use of diazepam to control bouts of increased seizure activity
for patients 2 years and older.
In clinical trials with DIASTAT
®, the most frequent side effect was somnolence
(23%). Less frequent adverse events reported were dizziness, headache, pain,
vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal
pain, nervousness and rhinitis (1%-5%). Please see full
DIASTAT AcuDial Prescribing Information.